Home › Takeda Pharmaceuticals U.S.A., Inc. › Anti-Drug Antibody Biomarker Specimen Collection Kit
Anti-Drug Antibody Biomarker Specimen Collection Kit
Takeda Pharmaceuticals U.S.A., Inc. · Model 5000833 · UDI-DI 00850025688888
PQD
Prescription
0
510(k) clearances
19
Adverse events
1
Recalls
53
Facilities
Description
The purpose of the Anti-Drug Antibody and Biomarker Specimen Collection Kit is to aid healthcare providers (HCPs) in collectingspecimens from patients receiving ELAPRASE® or VPRIV® commercial therapy for the treatment of Hunter syndrome and Gaucher disease
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2022-03-16 | LetsGetChecked Inc. | Users received sample collection kits that were assigned to another user. Incorrect shipping labels were applied to the collection kits. As a result, a number of users received sa |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.